Myonexus Therapeutics, Inc. Email Format
Pharmaceutical ManufacturingOhio, United States2-10 Employees
Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first-ever, corrective treatments for Limb-girdle muscular dystrophy (LGMD) Types 2E, 2D, 2B, 2C, and 2L.